$4.27
-0.03 (-0.70%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+620.6% upside
Low Target
$21.48
Average Target
$30.77
High Target
$35.71
Current Price
$4.27
Current
$4.27
$4.27
Target
$30.77
$30.77
$21.48
$30.77 avg
$35.71
Scenario Analysis
Bear Case
$21.48
403.0%
Low target
Base Case
$30.77
+620.6%
Avg target
Bull Case
$35.71
+736.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$71.50
-94.0% from high
52-Week Low
$3.18
+34.2% from low
Target vs 52W High
$30.77
-57.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |